Cargando…
Upadacitinib for rheumatoid arthritis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572193/ https://www.ncbi.nlm.nih.gov/pubmed/33093749 http://dx.doi.org/10.18773/austprescr.2020.053 |
Ejemplares similares
-
The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan
por: Yamaoka, Kunihiro, et al.
Publicado: (2021) -
Lymphomatoid papulosis during upadacitinib treatment for rheumatoid arthritis
por: Iinuma, Shin, et al.
Publicado: (2022) -
Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
por: Sanmartí, Raimon, et al.
Publicado: (2023) -
The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients
por: Aslani, Mona, et al.
Publicado: (2020) -
The role of upadacitinib in the treatment of moderate-to-severe
active rheumatoid arthritis
por: Avci, Ali Berkant, et al.
Publicado: (2021)